Merck & Co., Inc. Realized Investment Gains (Losses)
Merck & Co., Inc. (MRK) reported Realized Investment Gains (Losses) of -$231.00 million for the 12-month period ending 2009-12-31, per its 10-K filed 2011-02-28.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RealizedInvestmentGainsLosses · last filed 2011-02-28
- Merck & Co., Inc. realized investment gains (losses) for the quarter ending 2009-06-30 was $82.00M.
- Merck & Co., Inc. realized investment gains (losses) for fiscal 2009 was -$231.00M.
- Merck & Co., Inc. realized investment gains (losses) for fiscal 2008 was -$117.00M.
| Period end | Realized Investment Gains (Losses) 3 month | Realized Investment Gains (Losses) 6 month | Realized Investment Gains (Losses) 12 month |
|---|---|---|---|
| 2009-12-31 | -$231.00M 10-K · filed 2011-02-28 | ||
| 2009-06-30 | $82.00M 10-Q · filed 2010-08-06 | $99.00M 10-Q · filed 2010-08-06 | |
| 2008-12-31 | -$117.00M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |